Department of Dermatology, Venerology und Allergology, Leipzig University, 04103 Leipzig, Germany.
Acta Biomater. 2013 Mar;9(3):5621-9. doi: 10.1016/j.actbio.2012.11.016. Epub 2012 Nov 17.
The sequential phases of biomaterial integration and wound healing require different macrophage functions mediated by distinct macrophage subsets. During the initial phase of healing, pro-inflammatory M1 macrophages (MΦ1) are required to clear the wound from microbes and debris; however, their unopposed, persistent activation often leads to disturbed integration of biomaterials and perturbed wound healing. Here we investigated whether pro-inflammatory macrophage functions are affected by immunomodulatory biomaterials based on artificial extracellular matrices (aECM). To address this issue, we tested the capacity of two-dimensional aECM consisting of collagen I and hyaluronan or sulfated derivatives of hyaluronan to affect functions of in vitro polarized human pro-inflammatory MΦ1. The aECM containing high-sulfated hyaluronan substantially decreased inflammatory macrophage functions, including pathogen uptake and release of the pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-12 due to impaired activation of nuclear factor "kappa-light-chain-enhancer" of activated B-cells. Moreover, these macrophages secreted immunregulatory IL-10 and showed reduced activity of the transcription factors signal transducer and activator of transcription 1 and interferon-regulating factor 5, both controlling macrophage polarization to MΦ1 subsets. Our data reveal that the collagen I matrix containing high-sulfated hyaluronan possesses immunomodulating properties and dampens inflammatory macrophage activities by impeding signaling pathways crucial for polarization of pro-inflammatory MΦ1. We therefore suggest this aECM as a promising coating for biomaterials to modulate inflammatory macrophage functions during the healing response and recommend its further testing as a three-dimensional construct and in in vivo models.
生物材料整合和伤口愈合的连续阶段需要不同巨噬细胞功能,这些功能由不同的巨噬细胞亚群介导。在愈合的初始阶段,需要促炎 M1 巨噬细胞(MΦ1)来清除伤口中的微生物和碎片;然而,它们的无拮抗、持续激活常常导致生物材料整合紊乱和伤口愈合受损。在这里,我们研究了基于人工细胞外基质(aECM)的免疫调节生物材料是否会影响促炎巨噬细胞的功能。为了解决这个问题,我们测试了由胶原蛋白 I 和透明质酸或透明质酸的硫酸化衍生物组成的二维 aECM 对体外极化的人类促炎 MΦ1 功能的影响。含高硫酸化透明质酸的 aECM 显著降低了炎症性巨噬细胞的功能,包括病原体摄取和促炎细胞因子肿瘤坏死因子-α和白细胞介素-12 的释放,这是由于激活 B 细胞的核因子“κ轻链增强子”的激活受损。此外,这些巨噬细胞分泌免疫调节的白细胞介素 10,并显示转录因子信号转导和转录激活因子 1 和干扰素调节因子 5 的活性降低,这两种因子都控制着巨噬细胞向 MΦ1 亚群的极化。我们的数据表明,含有高硫酸化透明质酸的胶原蛋白 I 基质具有免疫调节特性,通过阻碍极化促炎 MΦ1 的关键信号通路来抑制炎症性巨噬细胞的活性。因此,我们建议将这种 aECM 作为生物材料的一种有前途的涂层,以在愈合反应中调节炎症性巨噬细胞的功能,并建议进一步将其作为三维结构和在体内模型中进行测试。